Blackstone Group »

Lexeo Therapeutics shares owned by Blackstone Group

Quarter-by-quarter ownership of Lexeo Therapeutics (LXEO) shares owned by Blackstone Group from 13F filings

Historical chart of Blackstone Group investment in Lexeo Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lexeo Therapeutics held by Blackstone Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lexeo Therapeutics by Blackstone Group

Quarter filed Position value Share count Share price at filing
2024-09-30 $11M 1.2M 9.04
2024-06-30 $13M 806k 16.04
2024-03-31 $11M 696k 15.68
2023-12-31 $9.3M 696k 13.42